Meeting News
October 14, 2019
CHICAGO — Among elderly patients with a spinal cord injury, researchers found the risk of morality was greater when patients had an increased…
Commentary
October 14, 2019
Diabetes affects 425 million people worldwide, and 1 in 2 adults remains undiagnosed, according to the International Diabetes Federation Diabetes…
October 14, 2019
As liver cancer rates continue to increase globally, researchers have focused on novel treatment options including combination therapies and…
Trial Scorecards
Cardiology Today, October 2019
Researchers evaluated the effect of twice-daily ticagrelor (Brilinta, AstraZeneca) on CV death, MI or stroke in patients with type 2 diabetes.
Trial Scorecards
Cardiology Today, October 2019
Evaluation of the efficacy, safety and tolerability of a subcutaneous injection of inclisiran (The Medicines Company).
Trial Scorecards
Cardiology Today, October 2019
Assessment of sacubitril/valsartan (Entresto, Novartis) vs. valsartan in patients with HF with preserved ejection fraction.
Trial Scorecards
Cardiology Today, October 2019
Assessment of safety and efficacy of ticagrelor (Brilinta, AstraZeneca) vs. prasugrel (Effient, Daiichi Sankyo/Eli Lilly) in patients with ACS for…
Trial Scorecards
Cardiology Today, October 2019
Researchers assessed bleeding risk of edoxaban (Savasya, Daiichi Sankyo) plus a P2Y12 inhibitor vs. a vitamin K antagonist, a P2Y12 inhibitor and…
Drug Risk Update
Cardiology Today, October 2019
Raymond L. Woosley, MD, PhD; C. Will Heise, MD; Jared Tate, PharmD; Tyler Gallo, PharmD; David Woosley, MPH; Klaus Romero, MS, MD
CredibleMeds, a valuable resource for prescribing physicians, now includes information from FDA drug labels to inform prescribers of any ECG…
Trial Scorecards
Cardiology Today, October 2019
Researchers compared dapagliflozin (Farxiga, AstraZeneca) vs. placebo for HF-specific biomarkers, symptoms, health status and quality of life in…
Trial Scorecards
Cardiology Today, October 2019
Study of complete revascularization vs. no further revascularization in patients with STEMI and multivessel CAD who had successful culprit-lesion…
Trial Scorecards
Cardiology Today, October 2019
Researchers compared outcomes of dapagliflozin (Farxiga, AstraZeneca) vs. placebo in patients with HF with reduced ejection fraction with or without…
Cover Story
Cardiology Today, October 2019
The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated…
Feature
October 14, 2019
CDC data show that 16.2% of pregnant women aged 18 to 44 years reported using marijuana nearly every day. These findings recently prompted U.S…
Feature
October 14, 2019
Women who underwent combined breast, plastic reconstructive and gynecologic surgery exhibited higher rates of postoperative complications…
Feature
October 14, 2019
Clinical practice guidelines issued last year recommended against routinely testing patients for Clostridioides difficile if they have received a…
In the Journals
October 14, 2019
Secondary Sjögren’s syndrome affects approximately one-quarter of all patients with systemic lupus erythematosus, and the frequency increases…
Meeting News
October 13, 2019
SAN FRANCISCO — Corneal irregularities and opacities should be diagnosed and treated before surgery, according to a speaker here. “These…
Meeting News
October 13, 2019
SAN FRANCISCO — American Academy of Ophthalmology representatives are emphasizing the need to apply office visit Evaluation and Management code…
Meeting News
October 13, 2019
SAN DIEGO — While the executive order signed by president Donald J. Trump last July to set new goals for increasing transplant rates has…